Device Trial Radar · NCT02615379
Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion
Last checked: Nov 20, 2026Latest source record: Aug 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jul 1, 2017
Primary completion
Dec 31, 2017
Study completion Mar 31, 2019
Sponsor
- Lead sponsor
- Neogenix, LLC dba OgenixNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 26, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).
Conditions
- Instrumented Spinal Fusion
Interventions
EPIFLODevice
Transdermal continuous oxygen therapy is oxygen delivery to the wound site directly. Ogenix makes a small portable oxygen concentrator (Trade Name: EPIFLO) that makes continuous transdermal delivery of oxygen possible. It is a 3 ounce oxygen generator that continuously delivers 3 ml of pure oxygen to the wound site.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of surgical site infectionTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Neurological Surgery Allegheny General Hospital
Pittsburgh, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.